Tag: luteinizing hormone-releasing hormone agonist

Patient-reported outcomes differ significantly based on treatment in prostate cancer: The ProtecT trial

Transdermal estrogen shows similar cardiovascular safety profile to traditional luteinizing hormone therapy in patients with prostate cancer

byMichael Pratteand1 others

February 25, 2021

1. The use of long-term transdermal estrogen for castration therapy for prostate cancer showed no difference in cardiovascular events versus ...

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

No Result

View All Result

Tag: luteinizing hormone-releasing hormone agonist

Transdermal estrogen shows similar cardiovascular safety profile to traditional luteinizing hormone therapy in patients with prostate cancer

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2MM+ Premium Access

Recent Reports